siRNA, Anti-Human ANXA13, LNA(CAT#: SIRGT04201WQ-LNA)

The product SIRGT04201WQ-LNA is a type of small interfering RNA (siRNA) that targets ANXA13 gene and regulates the expression of gene. The siRNA interferes with the expression of ANXA13 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001003954.2; NM_004306.3
Alternative Names ANX13; ISA
Related Diseases Miyoshi Muscular Dystrophy
Purification HPLC
Target Gene
Gene ID 312
Uniprot ID P27216

Related Products